Farther Finance Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
ETC
Farther Finance Advisors's BMY Position: Q2 2026 in Review
Farther Finance Advisors increased its Bristol-Myers Squibb (BMY) stake by 30% in Q2 2026, buying an estimated $1.96M and bringing the position to 148,017 shares worth $8.53M. The position accounts for 0.07% of the portfolio, ranked #253.
Farther Finance Advisors first reported a position in BMY in Q4 2022 and has held it in 15 quarters since. 801 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Farther Finance Advisors held 148,017 shares of Bristol-Myers Squibb worth $8.53M as of Q2 2026.
- Farther Finance Advisors bought 34,076 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.96M.
- Bristol-Myers Squibb made up 0.07% of Farther Finance Advisors's portfolio in Q2 2026, its #253 holding.
- Farther Finance Advisors first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 15 quarters since.
- 801 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.